The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

The Oncology Institute, Inc.NASDAQ: TOI

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow growth accelerates

Q1 FY2026 investing cash flow of $1.04M (cash outflow) rose 415.8% year over year, ahead of the -114.7% change in trailing-twelve-month investing cash flow. Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at -71.4% a year.

Context

  • Investing cash flow amounted to 0.6% of revenue in FY2025, down 11.1 pp from a year earlier.
  • Investing cash flow increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +415.8% holds above the trailing-twelve-month pace of -114.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.04M-1.7% QoQ
Last fiscal yearDec 2025
-$3.07M-106.7% YoY
LTMMar 2026
-$3.91M-114.7% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+415.8%——
1 year-106.7%——
3-year CAGR-71.4%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(3.07M) USD
Year-over-year change
-106.7%

Investing Cash Flow vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -114.7% is the lowest of 10, against a peer median of +100.4%.
  • Investing cash flow amounts to 0.7% of revenue for TOI, versus a peer median of 3.5%.
TOI Competitors
Investing Cash Flow for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNDASonida Senior Living, Inc.LTM Mar 2026$986.08M USD+365.7%+24.2%239.4%
AUTLAutolus Therapeutics plcLTM Mar 2026$314.16M USD+169.3%—339.3%
AGLAgilon Health, Inc.LTM Mar 2026$130.97M USD+100.4%—2.3%
CBLLCeriBell, Inc.LTM Mar 2026$66.09M USD+112.7%+338.7%69.5%
AUNAAuna S.A.LTM Mar 2026PEN 44.92M PEN-83.3%-70.9%1.0%
KIDSOrthoPediatrics Corp.LTM Mar 2026$41.43M USD+167.8%-27.3%17.0%
EOLSEvolus, Inc.LTM Mar 2026$8.28M USD+40.7%+42.2%2.7%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$7.73M USD-7.8%-42.9%0.8%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$7.33M USD-75.3%—3.5%
TOIThe Oncology Institute, Inc.LTM Mar 2026$3.91M USD-114.7%-71.4%0.7%
Peer median (excluding TOI) —+100.4%-1.5%3.5%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.93M)152K(83.07M)(53.01M)(60.61M)
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
Deferred Income Tax(1.24M)(263K)(76K)0(32K)
Stock-Based Compensation24.54M27.68M17.81M11.15M4.55M
Change in Working Capital(14.49M)(20.54M)2.36M18.06M1.33M
Accounts Receivables(2.99M)(19.67M)(4.5M)(5.77M)(12.58M)
Inventory(1.84M)(1.73M)(4.39M)3.64M(6.84M)
Accounts Payables2.92M(6.19M)5.06M9.22M19.64M
Other Working Capital(12.58M)7.04M6.19M10.98M1.11M
Other Non-Cash Items(33.9M)(73.2M)20.79M2.12M23.23M
Operating Cash Flow(32.68M)(61.76M)(36.32M)(26.54M)(24.59M)
Capital Expenditures(3.05M)(5.53M)(4.57M)(3.79M)(3.2M)
Acquisitions (Net)(9.11M)(8.58M)(4.46M)00
Purchases of Investments0(117.51M)(9.6M)00
Sales of Investments0081.26M50M126K
Other Investing Activities(200K)0000
Investing Cash Flow(12.15M)(131.61M)62.64M46.21M(3.07M)
Debt Repayment(7.25M)109.94M(101K)(39K)(20.04M)
Common Stock Issued00075K32.63M
Common Stock Repurchased0(9M)(1.02M)00
Dividends Paid00000
Other Financing Activities141.26M(8.74M)(5.73M)(3.53M)(1.04M)
Financing Cash Flow154.01M92.21M(6.85M)(3.49M)11.56M
Effect of Forex Changes00000
Net Change in Cash109.18M(101.16M)19.48M16.18M(16.1M)
Free Cash Flow(35.73M)(67.29M)(40.88M)(30.33M)(27.79M)

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.